Princeton Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Princeton Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-726	Closed	-$6.36K	–	105
2023 Q3	$6.36K	Sell	726 -93	-11%	-$871	﹤0.01%	88
2023 Q2	$9.62K	Sell	819 -3,080	-79%	-$44.3K	﹤0.01%	93
2023 Q1	$66.8K	Sell	3,899 -159	-4%	-$3.44K	0.03%	93
2022 Q4	$107K	Sell	4,058 -1,405	-26%	-$66.7K	0.05%	92
2022 Q3	$554K	Buy	5,463 +126	+2%	+$17K	0.24%	62
2022 Q2	$754K	Buy	5,337 +298	+6%	+$41.6K	0.29%	58
2022 Q1	$795K	Buy	5,039 +8	+0.2%	+$1.29K	0.25%	65
2021 Q4	$1.12M	Sell	5,031 -90	-2%	-$17.4K	0.32%	59
2021 Q3	$988K	Buy	5,121 +710	+16%	+$151K	0.32%	55
2021 Q2	$1.06M	Buy	+4,411	New	+$1.21M	0.33%	56

Other funds holding TFFP

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Princeton Capital Management's TFFP Position: Q4 2023 in Review

Princeton Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 726 shares — an estimated $6.36K sold.

Princeton Capital Management first reported a position in TFFP in Q2 2021 and held it in 10 quarters. The position peaked at $1.12M in Q4 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

Princeton Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Princeton Capital Management sold 726 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $6.36K.
Princeton Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Princeton Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $1.12M in Q4 2021.
23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Princeton Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.